deltatrials
Completed PHASE4 INTERVENTIONAL 3-arm NCT03700411

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery (POACC-1)

Influence of Peri-operative Opioid Analgesia on Circulating Tumor Cells in Patients Undergoing Open Colorectal Cancer Surgery - Multi-center, Randomized Clinical Trial

Sponsor: General University Hospital, Prague

Updated 9 times since 2018 Last updated: Dec 6, 2023 Started: Jan 7, 2019 Primary completion: Nov 1, 2023 Completion: Dec 6, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Circulating Tumor Cell and Colorectal Cancer, this trial is completed. The trial is conducted by General University Hospital, Prague and has accumulated 9 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Nov 2018 – ~Apr 2019 · 5 months · monthly snapshotNot Yet Recruiting~Apr 2019 – ~Aug 2020 · 16 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotRecruiting~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~Oct 2023 · 21 months · monthly snapshotRecruiting~Oct 2023 – ~Jan 2024 · 3 months · monthly snapshotRecruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2024 — Jul 2024 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  4. Oct 2023 — Jan 2024 [monthly]

    Recruiting PHASE4

  5. Jan 2022 — Oct 2023 [monthly]

    Recruiting PHASE4

Show 4 earlier versions
  1. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

  2. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  3. Apr 2019 — Aug 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  4. Nov 2018 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • General University Hospital, Prague
  • Hospital Novy Jicin
  • The Institute of Molecular and Translational Medicine, Czech Republic
  • Tomas Bata Hospital, Czech Republic
  • University Hospital Ostrava
Data source: The Institute of Molecular and Translational Medicine, Czech Republic

For direct contact, visit the study record on ClinicalTrials.gov .